Kadmon Corporation to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

Kadmon Corporation to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

ID: 404860

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 07/06/15 -- Kadmon Corporation, LLC, today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer of Kadmon, will present at the Cantor Fitzgerald Inaugural Healthcare Conference on Wednesday, July 8, 2015 at 4:45 p.m. ET in New York City. Dr. Waksal will provide an overview of Kadmon and its clinical and commercial programs.

In addition, Samuel D. Waksal, Ph.D., Founder and Chief of Innovation, Science and Strategy at Kadmon, will participate in a panel discussion at the conference, titled "Continued Opportunities in Immuno-Oncology: Exploring Next-Generation Checkpoint Inhibition," to take place at 11:15 a.m. ET.

Kadmon Corporation, LLC, is a vertically integrated biopharmaceutical company focused on developing innovative products for significant unmet medical needs. We have a diversified product pipeline in autoimmune and fibrotic diseases, oncology, monogenic diseases and metabolic disease. For more information, visit .

This press release contains forward-looking statements. These forward-looking statements are based on management's expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. The information contained in this press release is believed to be current as of the date of original issue. Kadmon expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.



Ellen Tremaine
Investor Relations
646.490.2989



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (Glycerol Phenylbutyrate) Oral Liquid Theravance Biopharma to Present at the Wedbush PacGrow Healthcare Conference
Bereitgestellt von Benutzer: Marketwired
Datum: 06.07.2015 - 13:30 Uhr
Sprache: Deutsch
News-ID 404860
Anzahl Zeichen: 0

contact information:
Town:

NEW YORK, NY



Kategorie:

Trials



Diese Pressemitteilung wurde bisher 209 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at the Cantor Fitzgerald Inaugural Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von

Kadmon Corporation (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Kadmon Issues Statement on Rosenfeld Lawsuit ...

NEW YORK, NY -- (Marketwired) -- 06/23/16 -- Kadmon Corporation, LLC today issued the following statement in response to a press release issued on June 22, 2016 from counsel for plaintiff Steven Rosenfeld, regarding the action he commenced on Februa ...

Alle Meldungen von Kadmon Corporation



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z